The Pharmaceutical Industry Network Group (PING)
The pharmaceutical ecosystem is constantly evolving, with participants facing many challenges, market shifts and innovation opportunities.
PING is a thriving and diverse networking group that brings together those across the industry, facilitating connections, idea-sharing, and support, with the collective aim of strengthening the sector for everyone involved.
At PING, you will connect with those across the pharma ecosystem, from early-stage R&D (such as universities and research institutes) through to finished product suppliers (originators and generics) and distributors and wholesalers (any marketing authorisation holders) and ultimately some pharmacists too.
There are others who are involved in that supply chain, such as data analysts, health economists, market access specialists, qualified persons, etc. Each member contributes unique insights, making PING a dynamic space for collaboration and growth.
Chaired by Paul Gershlick, Head of Pharmaceuticals and Life Sciences, the group is proudly supported by Hertfordshire Futures, which has the objective of enhancing the sector in the region as a centre of excellence and facilitating the spread of good industry practice.
At PING, businesses and individuals operating across the entire pharma ecosystem can get a holistic experience of the sector, explore topical issues together and share insights. Attendees also value the opportunity to connect with like-minded people and make important business connections.
Our expertise
Awarded ‘Most Innovative Marketing Idea’ by the Legal 360 Group, PING continues to provide valuable opportunities to grow, collaborate, and stay ahead in a fast-evolving industry.
With its base in Hertfordshire, PING taps into a vibrant local ecosystem that supports pharmaceutical and life sciences businesses. This includes organisations such as the Stevenage Bioscience Catalyst, the University of Hertfordshire, and the Cell and Gene Therapy Catapult. We are proud to be an active part of this thriving community, driving growth and innovation in the sector, and giving clients and contacts a network of like-minded individuals.
What is PING?
The annual PING conference is a valuable opportunity to hear from thought leaders and industry experts, while connecting with your peers in a relaxed atmosphere. It is the perfect setting to share experiences, build your profile, and make meaningful industry connections. Recent conference sessions have included:
- AI in pharma - Threat or opportunity? - Featuring industry leaders from Eularis, BenevolentAI, Healx, Ignota Labs, Charles River Laboratories, Curenetics, health-equity.ai, 7bridges, Camino Communications
- Post Brexit and COVID Life Sciences Challenges - Insights from MHRA, MedCity, Pioneer Group, Science Creates, Precision Health Tech Accelerator, 3PM
- The Golden Age for Life Sciences Innovation - Presentations from the Government, NICE, NHS England & Improvement, Accelerated Access Collaborative, Our Future Health, BGF, Parkwalk Advisors
We welcome suggestions on what topics are most interesting and pressing for those in the sector. Please get in touch with us if you would like to hear about a particular issue at our next PING conference.
The award celebrates individuals and organisations whose innovative work in pharmaceuticals and life sciences is making a real impact. This award recognises groundbreaking ideas, products, and services that are improving lives and driving progress in the sector. It is an opportunity to shine a spotlight on the innovators who are shaping the future of the industry.
Last year's award was presented to health-equity.ai at the annual PING Conference.
Our roundtable meetings provide an intimate setting for in-depth discussions on the most pressing issues in the pharmaceutical sector. With around 20 attendees from different parts of the industry, these meetings offer fresh perspectives, opportunities for learning, and valuable business connections.
Innovation is the lifeblood of progress, especially in the life sciences sector. By highlighting the achievements of these winners, we not only honour their contributions but also inspire others to push the boundaries of what's possible.
Discover more
- Articles
The renewed Women's Health Strategy for England - a catalyst for change?
On 15 April 2026, the UK government published its renewed Women's Health Strategy ("Renewed Strategy") for the next 10 years. We explore what has been promised.
- Articles
Manufacturing investment announcements paint exciting future for UK life sciences
Three pharma manufacturing investments of over £80 million have dramatically boosted UK life sciences prospects. They support the Life Sciences Sector Plan, which looks to make the UK the number one life sciences economy in Europe by 2030 and third in the world by 2035.
